rhamnogalacturonan-i has been researched along with Stomach-Ulcer* in 2 studies
2 other study(ies) available for rhamnogalacturonan-i and Stomach-Ulcer
Article | Year |
---|---|
Gastroprotective effects and structural characterization of a pectic fraction isolated from Artemisia campestris subsp maritima.
The aim of this study was to investigate the chemical structure and biological activity of a pectic fraction isolated from the aerial parts of A. campestris L. subsp. maritima Arcangeli. The chemical and spectroscopic analyses of the pectic fraction (ACP-E10) demonstrated that ACP-E10 was composed of homogalacturonan (HG) (60%) and rhamnogalacturonan-I (RG-I) (29%) regions. Side chains of the RG-I included mainly branched arabinans and type II arabinogalactans (AG-II). The molar mass of ACP-E10 determined by HPSEC-MALLS was 16,600g/mol. ACP-E10 was evaluated for its gastroprotective effect against ethanol-induced gastric lesions in rats. Oral pretreatment of animals with ACP-E10 (0.3, 3 and 30mg/kg) significantly reduced gastric lesions by 77±7.9%, 55±11.1% and 65±11.8%. ACP-E10 also maintained mucus and glutathione (GSH) contents in the gastric mucosa. In addition, ACP-E10 demonstrated antioxidant activity in vitro by the DPPH assay. These results demonstrated that the pectin from A. campestris had significant gastroprotective effects in vivo, which were likely attributable to their capacity to increase the protective defenses of gastric mucosa. Topics: Animals; Anti-Ulcer Agents; Artemisia; Ethanol; Gastric Mucosa; Humans; Mucoproteins; Pectins; Phytotherapy; Plant Leaves; Plant Proteins; Polysaccharides; Rats; Stomach Ulcer | 2018 |
Modified pectic polysaccharide from turmeric (Curcuma longa): A potent dietary component against gastric ulcer.
Native, intact (TrPP) and modified, low-molecular-weight (MTrPP) forms of pectic polysaccharides isolated from turmeric were evaluated for ulcer-preventive potentials in in vitro and in vivo models. Data indicated that MTrPP possessed significantly better ulcer-preventive property than TrPP; inhibiting ulcer scores up to 85%. Results were substantiated by effective muco-protection, H(+),K(+)-ATPase down-regulation, inhibition of H. pylori growth/adherence, higher antioxidant/cytoprotective mechanisms. Structural data indicated TrPP and MTrPP differ in their molecular weights and structural characteristics with different sugar compositions and side chain ratios. MTrPP was rich in galacturonic acid (687mg/g; TrPP-544mg/g) and galactose (52.9%; TrPP-21.7%). Results were substantiated by NMR/FTIR data indicating the presence of homogalacturonan and rhamnogalacturonam-I containing galactans. By virtue of binding to inflammatory marker (galectin-3), galactans may reduce inflammation induced ulcerations. The low molecular weight of MTrPP (155kDa; TrPP-13kDa) may increase its bioavailability than TrPP, thus MTrPP may possess higher antiulcer potential. Topics: Anti-Ulcer Agents; Antioxidants; Cell Line; Curcuma; Down-Regulation; Galactose; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Helicobacter pylori; Hexuronic Acids; Humans; Magnetic Resonance Spectroscopy; Molecular Weight; Pectins; Polysaccharides; Spectroscopy, Fourier Transform Infrared; Stomach Ulcer | 2016 |